Mustang Bio Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Mustang Bio Inc
Access all reports
Mustang Bio, Inc. is a biotechnology company focused on the development of cell and gene therapies for the treatment of cancer and rare genetic diseases. The company specializes in advancing innovative approaches such as chimeric antigen receptor (CAR) T-cell therapies and gene editing technologies. The company is headquartered in Worcester, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
MBIO
Country
🇺🇸 United States